Carl Lamm

Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag Acute Circulatory System, HeartMate II, PVAD, IVAD and for pediatric patients PediMag/PediVAS Acute Circulatory System. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures mechanical circulatory products to support the cardiovascular systems of humans and to provide product-related services. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA.

Varian, Inc. provides scientific instruments and vacuum technologies for life science, environmental, energy, applied research and other applications. The company offers instruments, vacuum products, laboratory consumable supplies, software, training and support services. It has manufacturing facilities in North America, Europe and Asia Pacific. Varian was founded in 1999 and is headquartered in Palo Alto, CA.

ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL.